- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03939091
Ultrasonographic Versus Renographic Parameters in Prediction of Early Success After Pyeloplasty in Children
May 3, 2019 updated by: Mohamed Abdelazeem, Mansoura University
Ultrasonographic Versus Renographic Parameters in Prediction of Early Success After Pyeloplasty in Children. A Prospective Study.
To study the predictive value of ultrasonographic (USG) parameters in the form of anteroposterior diameter , calyceal dilatation , calyx-to-parenchyma ratio , renal length , renal width , pelvis-to-cortex ratio (PCR) and parenchymal thickness versus renographic parameters in the form of T1/2 , differential renal function (DRF) and Tissue tracer transit (TTT) for early detection of children at risk of recurrent obstruction post unilateral pyeloplasty.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Outside U.S./Canada
-
Mansoura, Outside U.S./Canada, Egypt, 35516
- Recruiting
- Urology and nephrology center
-
Contact:
- Ahmed Shoma
- Phone Number: 502202222
- Email: ahmed.shoma@hotmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 14 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients who will be scedueled for pyeloplasty
Exclusion Criteria:
- bilateral pathology
- Pelvi-ureteric junction obstruction (PUJO) in a solitary kidney
- other associated anomalies
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Ultrasonography
Renal Ultrasonography
|
Renal Ultrasonography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
evaluate predictive value of ultrasonographic parameters for early detection of recurrent obstruction
Time Frame: 30 months
|
assessed by Diuretic scintigraphy (T1/2) as the time it takes for the activity in the kidney to decrease to 50% of its maximum value measured in minutes
|
30 months
|
evaluate predictive value of ultrasonographic parameters for early detection of decrease renal function
Time Frame: 30 months
|
assessed by Diuretic scintigraphy differential renal function (DRF) measured in millilitres/minute
|
30 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2018
Primary Completion (Anticipated)
June 1, 2020
Study Completion (Anticipated)
June 1, 2020
Study Registration Dates
First Submitted
April 23, 2019
First Submitted That Met QC Criteria
May 3, 2019
First Posted (Actual)
May 6, 2019
Study Record Updates
Last Update Posted (Actual)
May 6, 2019
Last Update Submitted That Met QC Criteria
May 3, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Renogram.US.Pyeloplasty
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ultrasonography
-
Peking Union Medical College HospitalNot yet recruitingNeuraxial Ultrasonography
-
Poitiers University HospitalCompletedUltrasonography | ObstetricsFrance
-
Università degli Studi di BresciaCompletedUltrasonography, PrenatalItaly
-
Centre Hospitalier Saint Joseph Saint Luc de LyonUnknownUltrasonography | DiaphragmFrance
-
Assuta Medical CenterUnknown
-
Rigshospitalet, DenmarkCompletedUltrasonography Skills
-
Yale UniversityCompletedUltrasonographyUnited States
-
University Tunis El ManarCompleted
-
University of MichiganCompletedUltrasonographyUnited States
Clinical Trials on Ultrasonography
-
Benha UniversityUnknownPostmenopausal BleedingEgypt
-
Ankara City Hospital BilkentNot yet recruitingObstructive Sleep Apnea | Respiratory Complication | Airway Edema
-
Waldfriede HospitalRecruiting
-
Cantonal Hosptal, BasellandInsel Gruppe AG, University Hospital BernRecruitingObstructive Sleep Apnea | Sleep-Disordered BreathingSwitzerland
-
Cairo UniversityRecruitingHypertension in PregnancyEgypt
-
Sohag UniversityNot yet recruitingHepatic Steatosis and Fibrosis in Rheumatoid Arthritis Patients
-
Assiut UniversityNot yet recruitingPlacenta Previa | Vaginal Bleeding | Antepartum Hemorrhage
-
Assiut UniversityNot yet recruitingPediatric Lymphoma
-
Zeynep Kamil Maternity and Pediatric Research and...RecruitingEndometriosis, Rectum | ULTRASONOGRAPHYTurkey
-
Stanford UniversityRecruiting